Delineating a full phenotype of health, neurodevelopment and adaptive functioning in children and young adults with Fetal Valproate Spectrum Disorder.

First published 26/01/2022

Last updated 23/04/2024

EU PAS number:

EUPAS45205

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

EUPAS45205-45352

English (774.81 KB - PDF)View document

Updated protocol

ConcePTION WP2 Demonstration 3. Protocol Version 2. 24.01.22

First published: 22/02/2024

English (768.53 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

EUPAS45205-45354

English (164.98 KB - PDF)View document

Composition of steering group and observers

EUPAS45205 Composition of Steering Group and Observers

English (53.51 KB - PDF)View document

EUPAS45205-45486

English (53.51 KB - PDF)View document

Delineating a full phenotype of health, neurodevelopment and adaptive functioning in children and young adults with Fetal Valproate Spectrum Disorder.

Secondary tabs

Share this page